INDRAMEDCOIndraprastha Medical Corporation Limited
Convert to ideaHealthcare · Healthcare Facilities
The verdict combines business quality, price and timing. Sign in free to see it.
Sign in freeMomentum from moving averages, Supertrend and RSI.
1 forensic issue found. Sign in to see which.
Valuation Metrics
Q2 FY2027Intrinsic value, Graham number and DCF against today's price
1 found · risk minor
Quality, growth, balance sheet and earnings quality behind the score
ⓘ Based on fundamental & forensic analysis. Always verify against official filings and consult a financial advisor.
Financial Metrics
Comparing Q2 FY2027 vs Q2 FY2026
| Quarter | Revenue | Net Profit | OPM | NPM | EPS | Int. Cover |
|---|---|---|---|---|---|---|
| Q2 FY2027 | ₹413 Cr | ₹54 Cr | 15.79% | 12.98% | ₹5.84 | 44.4x |
| Q1 FY2027 | ₹406 Cr | ₹56 Cr | 16.75% | 13.75% | ₹6.09 | 46.3x |
| Q4 FY2026 | ₹365 Cr | ₹42 Cr | 13.48% | 11.43% | ₹4.55 | 37.9x |
| Q3 FY2026 | ₹372 Cr | ₹41 Cr | 13.64% | 11.03% | ₹4.47 | 39.6x |
| Q2 FY2026 | ₹381 Cr | ₹49 Cr | 15.86% | 12.98% | ₹5.40 | 44.9x |
| Q1 FY2026 | ₹365 Cr | ₹51 Cr | 17.25% | 14.10% | ₹5.61 | 44.8x |
Momentum score, 1-year chart, moving averages, support and resistance.
Turnaround stage, and how each measure moved over 3 years against the company's own range.
Order wins, capex, pledges, rating actions and every material filing.
Management guidance, Q&A highlights and whether they delivered what they said.
The earnings call read across investor dimensions.
Promoter, FII and mutual fund holding, and what changed this quarter.
Similar-size peers in Healthcare Facilities
Compare with peers →Note: This comprehensive analysis combines technical data, fundamental data, and investment thesis. Always do your own research and consider your personal risk tolerance before investing.